These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3495241)

  • 1. Clinical implications of ribonucleoprotein antibody.
    Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
    Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in collagen diseases].
    Meyer O
    Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 8. Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease.
    Diaz-Jouanen E; Llorente L; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1977; 4(1):4-10. PubMed ID: 301941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
    Alarcón-Segovia D; Cardiel MH
    J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
    Cortés JJ; Mendoza F; Reyes PA
    J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF; Peltier AP; Appelboom T
    Nouv Presse Med; 1975 Jun; 4(25):1863-5. PubMed ID: 1080278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
    Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
    J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
    Balthazar PA; Gabriel Júnior A; de Oliveira DP; de Oliveira MA; Rosales T; Iglesias SS; Assad RL; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):249-53. PubMed ID: 3879739
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.
    Ginsburg WW; Conn DL; Bunch TW; McDuffie FC
    J Rheumatol; 1983 Apr; 10(2):235-41. PubMed ID: 6864677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.